MaxiMyo is the name given to the latest generation electrical muscle stimulation (EMS) system based upon continuous product development and evolution of a precursor EMS system over a period of almost twenty years. Termed the MaxiMyo 10, it is the first in a new range of products specifically developed for Medical applications.
The many treatments achievable with MaxiMyo provide the basis for profitable treatment centres, either allied to existing clinics, or on a standalone basis to provide flexible working opportunities in the home or clinic environment.
Our conservative projections show that earnings of over £500,000 per annum are achievable for a clinic equipped typically, with three or four MaxiMyo 10 systems. The payback on capital purchase is an equally impressive eight weeks based on increased clinic efficiency over conventional treatments.
However MaxiMyo will also provide a handsome income stream for smaller operations, with a single MaxiMyo 10 generating over £150,000 per year in a full year of operation. Our experience has shown that in many instances it can to provide a springboard to an increasingly wealthy lifestyle, based upon hiring staff to operate additional devices in a multiple installation clinic.
Numerous franchisees and sole operators attest to the success of the product line to date. The latest MaxiMyo 10 EMS, with the additional treatment opportunities available will build upon this success and offers a proven business proposition.
This Business Information Pack demonstrates the unique business opportunity that MaxiMyo represents both for existing clinic operators and new entrepreneurs alike.
This section provide the necessary background information to determine the business potential for the MaxiMyo system.
Income projections are based upon our own experiences and a conservative view of the number of treatment sessions that individuals and clinics can sensibly achieve. Clearly adjustments should be made for personal lifestyle factors and existing clinic operations. However there are two major benefits with the MaxiMyo that together will offer you a greater control over your potential income:
1. An increased client base when compared to the traditional areas of Physiotherapy Treatments.
2. Treatment times that are often less than half a typical session at half an hour , instead of the traditional hour.
In addition your clients would benefit from a reduction in the number treatment sessions they need to attend. This, while apparently counter-intuitive, means that a premium can be charged, per session increasing projected income. A typical number of sessions before recovery could be of the order of four treatments.
From an NHS or more importantly a private medical insurance perspective this would mean a quicker return to work, less time on sick pay therefore increasing their earning capacity and saving money 
Increased income potential over a 40 week year based on twelve half hour sessions per day against 6 hourly sessions give the following income projection:
With maximum of 16 treatments per day the increased income potential over a full year of 48 weeks, gives the following income projection:
The information on this page is designed to give the reader an outline of what is involved in the running of a MaxiMyo Clinic. MaxiMyo are looking for suitable operators with the appropriate knowledge to operate within its UK regional network.
The Regional Operators must be have suitable medical qualifications and be looking to increase their earnings or establish their own independent practice. If this is the case then MaxiMyo will assist in aiding the potential establishment to start operating with a proven set of treatment regimes, training and with the assistance of a practical partnership.
If interested to discuss this further the in the fisrt instance email or send a CV to clinics@ maximyo.com or telephone us on 0845-403 1014 for an informal discussion.
 Initial assessment takes fifteen or twenty minutes longer and is repeated every 10 sessions.
 MaxiMyo are working with insurance companies to identify cost benefit analyses in this area.